StreetInsider.com News Articles

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

SOUTH ORANGE, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced today that President and Chief Executive Officer Robert Banks will present at “Health, Wellness & Longevity,” presented by Maxim Group LLC, on Wednesday, July 22, 2026, at 10:00 a.m. ET.

Nephros will be taking part in Maxim’s virtual summit titled “Health, Wellness & Longevity.” Consumer wellness and scientific innovation are reshaping how people eat, drink, and pursue longer, healthier lives. In this virtual

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Mon, 20 Jul 2026 07:00:00 -0400

Northland Starts Nephros (NEPH) at Market Perform

Fri, 17 Jul 2026 06:58:25 -0400

(Updated - July 17, 2026 6:58 AM EDT)

Northland analyst Bobby Brooks initiates coverage on Nephros (NASDAQ: NEPH) with a Market Perform rating and a price target of $4.00.

The analyst commented: "NEPH is a commercial and medical-grade water filtration company - whose five-nanometer ultrafilter is the gold standard in preventing the spread of waterborne pathogens. While an impressive technology, the company historically struggled to consistently grow revenues - given facilities only placed orders after an outbreak occurred. This dynamic changed when new management took over in 2023, implementing a partnership approach to customers - which has led to an increase in

Northland Starts Nephros (NEPH) at Market Perform

Fri, 17 Jul 2026 06:58:25 -0400

(Updated - July 17, 2026 6:58 AM EDT)

Northland analyst Bobby Brooks initiates coverage on Nephros (NASDAQ: NEPH) with a Market Perform rating and a price target of $4.00.

Nephros added to Russell Microcap Index after 2026 reconstitution

Mon, 06 Jul 2026 07:00:40 -0400

Nephros, Inc. (NASDAQ: NEPH), a water filtration company serving medical and commercial markets, has been added to the Russell Microcap® Index following the 2026 annual reconstitution. The inclusion became effective after the U.S. market closed on June 26, 2026.

Membership in the Russell Microcap® Index, which lasts one year, also means automatic inclusion in the applicable growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily through market-capitalization rankings and style attributes.

Robert Banks, President and Chief Executive Officer, said the inclusion "will not only help deliver long-term value to our shareholders but increase our visibility with potential

Nephros added to Russell Microcap Index after 2026 reconstitution

Mon, 06 Jul 2026 07:00:40 -0400

Robert Banks, President and Chief Executive Officer, said the inclusion "will not only help deliver long-term value to our shareholders but increase our visibility with potential

Nephros Announces Inclusion in the Russell Microcap® Index

Mon, 06 Jul 2026 07:00:00 -0400

SOUTH ORANGE, N.J., July 06, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that the company has been added to the Russell Microcap® Index at the conclusion of the 2026 annual reconstitution. Nephros’ inclusion in the index became effective after the US market closed on June 26, 2026.

Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell

Nephros Announces Inclusion in the Russell Microcap® Index

Mon, 06 Jul 2026 07:00:00 -0400

Nephros Announces Inclusion in the Russell Microcap® Index

Mon, 06 Jul 2026 07:00:00 -0400

Nephros Announces Inclusion in the Russell Microcap® Index

Mon, 06 Jul 2026 07:00:00 -0400

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Thu, 18 Jun 2026 07:00:00 -0400

SOUTH ORANGE, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will host a virtual investor event titled, “Beyond Filtration: The Nephros Model in Action” on July 16th, 2026.

The event will provide investors and stakeholders with an inside look at how Nephros is redefining water safety and building a differentiated, scalable model beyond filtration products. Attendees will gain insight into how Nephros delivers value through a combination of responsive solutions,

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Thu, 18 Jun 2026 07:00:00 -0400

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Thu, 18 Jun 2026 07:00:00 -0400

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Thu, 18 Jun 2026 07:00:00 -0400

NEPHROS touts ultrafiltration as microplastic filter after EPA ruling

Tue, 16 Jun 2026 07:03:52 -0400

Nephros, Inc. (NASDAQ: NEPH) highlighted the capability of its ultrafiltration technology to capture microplastics and nanoplastics in drinking water, following a U.S. Environmental Protection Agency decision in April 2026 to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List (CCL 6).

Microplastics are plastic particles ranging from 1 micrometer to 5 millimeters in size, while nanoplastics measure smaller than 1 micrometer. The company states its ultrafiltration products are engineered with pore sizes as small as 5 nanometers, which it says enables size-based exclusion of both micro- and nanoplastic particles, in addition to bacteria

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

Tue, 16 Jun 2026 07:00:00 -0400

Follows U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List

Company underscores relevance of advanced filtration in addressing one of the fastest-growing concerns in water quality

SOUTH ORANGE, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today highlighted the capability of its ultrafiltration technology to effectively capture microplastics and nanoplastics before they enter the water, reinforcing the Company’s

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

Tue, 16 Jun 2026 07:00:00 -0400

Follows U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List

Company underscores relevance of advanced filtration in addressing one of the fastest-growing concerns in water quality

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

Tue, 16 Jun 2026 07:00:00 -0400

Follows U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List

Company underscores relevance of advanced filtration in addressing one of the fastest-growing concerns in water quality

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

Tue, 16 Jun 2026 07:00:00 -0400

Follows U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List

Company underscores relevance of advanced filtration in addressing one of the fastest-growing concerns in water quality